Chlorthalidone or Spironolactone for Patients With TRH and Advanced Chronic Kidney Disease?

HomeHypertensionAhead of PrintChlorthalidone or Spironolactone for Patients With TRH and Advanced Chronic Kidney Disease? No AccessArticle CommentaryRequest AccessAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessArticle CommentaryRequest AccessChlorthalidone or Spironolactone for Patients With TRH and Advanced Chronic Kidney Disease? Bertram Pitt and Richard J. Auchus Bertram PittBertram Pitt https://orcid.org/0000-0001-7703-0345 Divisions of Cardiology, University of Michigan, Ann Arbor. (B.P.) Search for more papers by this author and Richard J. AuchusRichard J. Auchus Correspondence to: Richard J. Auchus, Division of Metabolism, Endocrinology and Diabetes, Internal Medicine, University of Michigan, 1150 W Medical Center Dr, MSRB II, 5570B, Ann Arbor, MI 48109. Email E-mail Address: [email protected] https://orcid.org/0000-0001-6815-6181 Divisions of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor. (R.J.A.) Department of Pharmacology, University of Michigan, Ann Arbor. (R.J.A.) Endocrinology and Metabolism Section, Medicine Service, LTC Charles S. Kettles VA Medical Center, Ann Arbor, MI (R.J.A.). Search for more papers by this author Originally published1 Nov 2023https://doi.org/10.1161/HYPERTENSIONAHA.123.21962Hypertension. 2023;0FootnotesFor Sources of Funding and Disclosures, see page xxx.The opinions expressed in this article are not necessarily those of the editors nor the American Heart Association.Correspondence to: Richard J. Auchus, Division of Metabolism, Endocrinology and Diabetes, Internal Medicine, University of Michigan, 1150 W Medical Center Dr, MSRB II, 5570B, Ann Arbor, MI 48109. Email rauchus@med.umich.edu eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetails Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/HYPERTENSIONAHA.123.21962PMID: 37909173 Originally publishedNovember 1, 2023 PDF download Advertisement SubjectsHypertension